Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-01-29 ORBIMED ADVISORS LLC 10% owner Purchase +50,000 $14.99 $750K 3,022,760
2018-01-26 ORBIMED ADVISORS LLC 10% owner Purchase +22,760 $14.93 $340K 2,972,760
2018-01-24 ORBIMED ADVISORS LLC 10% owner Purchase +64,637 $14.91 $964K 2,950,000
2018-01-23 ORBIMED ADVISORS LLC 10% owner Purchase +4,363 $14.99 $65K 2,885,363
2018-01-22 ORBIMED ADVISORS LLC 10% owner Purchase +75,000 $14.98 $1.1M 2,881,000
2018-01-19 ORBIMED ADVISORS LLC 10% owner Purchase +74,931 $14.95 $1.1M 2,806,000
2018-01-12 ORBIMED ADVISORS LLC 10% owner Purchase +38,354 $14.50 $556K 2,731,069
2018-01-12 ORBIMED ADVISORS LLC 10% owner Purchase +28,446 $15.40 $438K 2,692,715
2018-01-11 ORBIMED ADVISORS LLC 10% owner Purchase +41,700 $13.65 $569K 2,664,269
2018-01-10 ORBIMED ADVISORS LLC 10% owner Purchase +170,338 $12.83 $2.2M 2,622,569
2017-11-20 Bazemore Todd Chief Operating Officer Grant or award · Stock Option (right to buy) +172,000 $19.60 $3.4M 172,000
2017-09-28 KOVEN ANDREW I Director Grant or award · Stock Option (right to buy) +25,920 25,920
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion +36,094 $0.68 $25K 36,094
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion +16,168 $0.68 $11K 52,262
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion +44,313 $2.30 $102K 96,575
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion +12,150 $3.34 $41K 108,725
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −36,094 0
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −16,168 1,880
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −44,313 18,247
2017-08-11 Brazzell Romulus K Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −12,150 149,985

Page 21 of 24 · 472 trades